Cidofovir-induced end-stage renal failure.
Vandercam
B
B
Department of General Internal Medicine, St-Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium.
Moreau
M
M
Goffin
E
E
Marot
J C
JC
Cosyns
J P
JP
Jadoul
M
M
D000998:Antiviral Agents / Q000009:adverse effects*; D000077404:Cidofovir; D003596:Cytosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000009:adverse effects*
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir